← Back to Search

Evidence-Based Practice Education for Dizziness (DIZZTINCT2 Trial)

N/A
Recruiting
Led By Kevin Kerber, MD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English or Spanish speaker
Age >= 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cumulative 4 weeks following index ed visit
Awards & highlights

DIZZTINCT2 Trial Summary

This trial evaluates evidence-based practices for common causes of dizziness to improve care delivery in the ED.

Who is the study for?
This trial is for adults over 18 who've been discharged from certain emergency departments in the last 48 hours with a primary diagnosis of dizziness or related vestibular disorders. Participants must be Kaiser Permanente members, speak English or Spanish, and able to consent. Those with severe trauma, previous study enrollment, or inability to consent are excluded.Check my eligibility
What is being tested?
The study tests how well evidence-based practices for managing dizziness (like BPPV) are implemented in emergency departments. It uses an enhanced strategy developed from prior research and assesses its effectiveness through a stepped-wedge design and randomized patient-level dissemination.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medications, traditional side effects aren't expected. However, participants may experience discomfort or anxiety when discussing medical conditions or during assessments.

DIZZTINCT2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English or Spanish.
Select...
I am 18 years old or older.
Select...
I was diagnosed with dizziness or balance issues as my main health problem.

DIZZTINCT2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cumulative 4 weeks following index ed visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and cumulative 4 weeks following index ed visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dizziness Handicap Inventory
Documentation of Dix-Hallpike Test/Canalith Repositioning Maneuver

DIZZTINCT2 Trial Design

6Treatment groups
Experimental Treatment
Active Control
Group I: Group 6: Post-CME with Chart Review OnlyExperimental Treatment1 Intervention
Physicians in hospitals that have received the DIZZTINCT educational intervention. Eligible patient will have their medical records abstracted to assess the main study outcome
Group II: Group 5: Post-CME with Standard Patient CareExperimental Treatment1 Intervention
Physicians in hospitals that have received the DIZZTINCT educational intervention. Patients have not receive the DIZZTINCT educational intervention
Group III: Group 4: Post-CME with Patient EducationExperimental Treatment2 Interventions
Physicians in hospitals that have received the DIZZTINCT educational intervention. Patients have receive the DIZZTINCT educational intervention
Group IV: Group 1: Pre-CME with Patient EducationExperimental Treatment1 Intervention
Physicians in hospitals that have not received the DIZZTINCT educational intervention. Patients have received the DIZZTINCT educational intervention
Group V: Group 2: Pre-CME with Standard Patient CareActive Control1 Intervention
Physicians in hospitals that have not received the DIZZTINCT educational intervention. Patients have not received the DIZZTINCT educational intervention
Group VI: Group 3: Pre-CME with Chart Review OnlyActive Control1 Intervention
Physicians in hospitals that have not received the DIZZTINCT educational intervention. Eligible patient will have their medical records abstracted to assess the main study outcome

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
829 Previous Clinical Trials
425,743 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
329 Previous Clinical Trials
98,350 Total Patients Enrolled
5 Trials studying Vertigo
8,552 Patients Enrolled for Vertigo
Kaiser PermanenteOTHER
538 Previous Clinical Trials
24,033,788 Total Patients Enrolled
1 Trials studying Vertigo

Media Library

Group 6: Post-CME with Chart Review Only Clinical Trial Eligibility Overview. Trial Name: NCT05634902 — N/A
Vertigo Research Study Groups: Group 2: Pre-CME with Standard Patient Care, Group 6: Post-CME with Chart Review Only, Group 1: Pre-CME with Patient Education, Group 3: Pre-CME with Chart Review Only, Group 4: Post-CME with Patient Education, Group 5: Post-CME with Standard Patient Care
Vertigo Clinical Trial 2023: Group 6: Post-CME with Chart Review Only Highlights & Side Effects. Trial Name: NCT05634902 — N/A
Group 6: Post-CME with Chart Review Only 2023 Treatment Timeline for Medical Study. Trial Name: NCT05634902 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently available for this clinical trial?

"Affirmative. According to clinicaltrials.gov, this experiment is currently accepting applications from participants; it was first posted on November 11th 2022 and the last edit occurred December 1st 2022. 80,000 volunteers are needed across one site for successful completion of the trial."

Answered by AI

What is the aggregate number of individuals taking part in this experiment?

"Affirmative, the trial is actively sourcing participants. This clinical investigation went up on 11/11/2022 and was most recently updated 12/1/2022. The study seeks 80000 individuals across a single site."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Kaiser Permanente Southern California
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
Recent research and studies
clinicaltrials.govStudy
Implementation of Evidence-Based Practice for Dizziness
Kevin Kerber 2022. "Implementation of Evidence-Based Practice for Dizziness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05634902.
All > Vestibular Migraine
~23333 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top